Modern Phenotypic Drug Discovery Is a Viable Pharma Strategy (Dec 5 | 11:30 am
EST | Free to SLAS members). Dr. Jonathan Lee, Eli Lilly and Company, describes a co-culture angiogenesis assay whose results indicate that modern phenotypic techniques can reliably provide information on compound structure-activity relationships during drug development.
Use of Human Induced Pluripotent Stem Cells for Predicting Diverse Cardiotoxicities
(Dec 11 | 11:00 am EST | Free). The Scientist brings together a panel of Pharma experts to discuss using human iPSC-derived cells in toxicological assays. Attendees are encouraged to share their experiences and ask questions during the live broadcast.